Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 广州万孚生物技术股份有限公司是一家专业致力于生物医药体外诊断试剂行业POCT领域产品研发、生产和销售的国家高新技术企业。现研发团队有116人，含博硕士30人，核心关键技术累计申请专利77项（含PCT5项），授权45项；其中申请发明专利29项（含香港发明2项，PCT发明3项），授权3项，核心品牌“wondfo”、“万孚”获得广州市著名商标称号。公司是国家发改委高技术产业化示范基地，是广东省中小企业创新产业化示范基地，现有30000㎡的产业化厂房，装配全球快速诊断试剂行业生产规模最大的金标生产线之一，日生产能力达100万人份；严格执行GMP/ISO9001：2008/ISO13485：2003质量管理体系，2009年国内首家“零缺陷”通过美国FDA现场考核的体外诊断试剂企业。公司产品以高新技术产品为主，涵盖传染病、妊娠、心血管疾病、毒品、肿瘤疾病、自身免疫疾病、糖尿病，食品安全检测和仪器试剂一体化等8个系列70多种。产品以质量赢得市场，获得欧洲CE认证57项，美国FDA认证30项，加拿大CAD认证7项。2009年甲流爆发时，在科技部主持的现场快速检测产品PK中获得免疫类第一名；2010年，万孚艾滋检测产品在全国CDC使用的同类产品中质量排名第一。为加快产品国际市场开拓和民族品牌国际化推广，公司在美国、德国、肯尼亚设立营销中心，并与欧洲零售巨头BOOTS、亚洲零售巨头WATSONS和南欧零售连锁著名品牌SONAE等成为战略合作伙伴。主要销往美国、欧洲、印度、尼日利亚等全球140多个国家和地区，年出口创汇逾千万美元。
Main Business 快速诊断试剂及配套仪器的研发、制造、营销及服务
Legal Representative 王继华
Top Executives
董事长：王继华
董事：李大立,赵亚平,彭仲雄
独立董事：段朝晖,李从东,欧阳文晋
Top 5 Shareholder
Shareholder name Nature Holding Date
李文美限售股20.32%30/09/2024
王继华限售股+流通A股10.30%30/09/2024
广州汇垠天粤股权投资基金管理有限公司流通A股10.22%30/09/2024
中国银行股份有限公司－华宝中证医疗交易型开放式指数证券投资基金流通A股1.96%30/09/2024
广州生物医药与健康产业投资有限公司流通A股1.87%30/09/2024
Company Secretary 胡洪
Solicitors 北京市君合律师事务所
Auditors 立信会计师事务所（特殊普通合伙）
Tel No 020-32215701
Fax No 020-32215701
Website www.wondfo.com.cn
Email stock@wondfo.com.cn
Company Address
Register: 广东省广州市萝岗区科学城荔枝山路8号、广东省广州市黄埔区神舟路268号
Office: 广东省广州市萝岗区科学城荔枝山路8号
Listing Date 30/06/2015
Shares Capital
Shares Capital: 481,424,071
Total A Share: 481,424,071
Listed A Share: 332,267,746
Non-tradable A Share: 149,156,325
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 1.100
DPS(RMB)* ¥ 0.400
NBV Per Share(RMB)* ¥ 9.917
Market Capitalization(RMB) 8.735B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.